Skip to main content

MARSHALL WACE, LLP

Position in EOLS — Evolus, Inc.

CIK 1318757 LONDON, X0

Position in EOLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$73,569
-$273,881 QoQ
Shares Held
17,900
-68.4% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. EOLS ranks #32 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EOLS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $73,569 17,900
2025-09-30 $347,450 56,588
2025-06-30 $624,861 67,846
2024-06-30 $2,190,061 201,849
2024-03-31 $3,056,200 218,300
2023-12-31 $5,828,628 553,526
2023-09-30 $6,172,753 675,356
2023-06-30 $7,538,073 1,036,874
2023-03-31 $938,307 110,911
2022-09-30 $1,504,335 186,874
2022-03-31 $189,651 16,903
2021-09-30 $1,947,191 255,537
2021-03-31 $3,482,917 268,123